Skip to content

N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine

C22H16F3N7 — CID 22944579

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACN-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine
SMILESCc1nn2c(C(F)(F)F)nn(C)c2c1/N=C1\N=C(c2ccccc2)N=C1c1ccccc1
InChIInChI=1S/C22H16F3N7/c1-13-16(20-31(2)30-21(22(23,24)25)32(20)29-13)26-19-17(14-9-5-3-6-10-14)27-18(28-19)15-11-7-4-8-12-15/h3-12H,1-2H3/b26-19-
InChIKeyBQMRPBSIIGQYGA-XHPQRKPJSA-N
MW435.41 g/mol
LogP4.37
Rot. Bonds3

About N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine

N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine (PubChem CID 22944579) has the molecular formula C22H16F3N7 and a molecular weight of 435.41 g/mol. Its IUPAC name is N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine.

Molecular Properties

Compound NameN-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine
PubChem CID22944579
Molecular FormulaC22H16F3N7
Molecular Weight435.41 g/mol
Exact Mass435.14
IUPAC NameN-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine
SMILESCc1nn2c(C(F)(F)F)nn(C)c2c1/N=C1\N=C(c2ccccc2)N=C1c1ccccc1
InChIInChI=1S/C22H16F3N7/c1-13-16(20-31(2)30-21(22(23,24)25)32(20)29-13)26-19-17(14-9-5-3-6-10-14)27-18(28-19)15-11-7-4-8-12-15/h3-12H,1-2H3/b26-19-
InChIKeyBQMRPBSIIGQYGA-XHPQRKPJSA-N
XLogP4.37
TPSA72.20 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms32
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500435.41
LogP ≤ 54.37
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine?
The IUPAC name of N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine (CID 22944579) is N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine.
What is the SMILES notation for N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine?
The canonical SMILES for N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine is Cc1nn2c(C(F)(F)F)nn(C)c2c1/N=C1\N=C(c2ccccc2)N=C1c1ccccc1.
What is the InChIKey of N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine?
The InChIKey is BQMRPBSIIGQYGA-XHPQRKPJSA-N. The full InChI is InChI=1S/C22H16F3N7/c1-13-16(20-31(2)30-21(22(23,24)25)32(20)29-13)26-19-17(14-9-5-3-6-10-14)27-18(28-19)15-11-7-4-8-12-15/h3-12H,1-2H3/b26-19-.
What are the key properties of N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine?
N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine has a molecular weight of 435.41 g/mol, XLogP of 4.37, 3 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine is sourced from PubChem (CID 22944579), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.